<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
Commission File Number
CUSIP Number:
Commission File Number
CUSIP Number:
NOTIFICATION OF LATE FILING
(Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F
[ X ] Form 10-Q [ ] Form N-SAR
For Period Ended: SEPTEMBER 30, 1997
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended: ______________________________________________
Read attached instruction sheet before preparing form. Please print
or type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates:_______________________________________________________________________
PART I. REGISTRANT INFORMATION
Full name of registrant: Rx Medical Services Corp.
Former name if applicable: ARM Financial Corp.
Address of principal executive office 888 East Las Olas Boulevard, Suite 210
City, State and Zip Code Fort Lauderdale, Florida 33301
PART II. RULE 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[ X ] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
[ ] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the 15th calendar day following the
prescribed due
<PAGE> 2
date; or the subject quarterly report or transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K,
20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period. (Attach extra sheets if needed.)
The Company does not anticipate that it will be able to fill its Form
10-Q for the period ended September 30, 1997 on or before the due date or the
extended due date pursuant to Rule 12b-25 for the following reason:
Certain information necessary for the accurate completion of the Form
10-Q for the second quarter ended June 30, 1997, is not available at the present
time.
Registrant anticipates that its Form 10-Q for the third quarter ended
September 30, 1997 will be filed on or about December 19, 1997.
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Joseph C. Wasch 954 462-1711 [Ext. 105]
- ---------------------- --- -------------------
(Name) (Area code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15
(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period
that the registrants were required to file such report(s) been filed? If the
answer is no, identify report(s).
[ ] Yes [ X ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [ X ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Rx MEDICAL SERVICES CORP.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date November 13, 1997 By /s/ Randolph H. Speer
----------------- --------------------------------------
Randolph H. Speer
President
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. the name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
sign on behalf of the registrant shall be filed with the form.
- -------------------------------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
